Pulmonx Corporation provided revenue guidance for the full year 2024 . The company expects revenue for the full year 2024 to be in the range of $81 million to $84 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 USD | -0.55% | +7.02% | -29.41% |
01/05 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
01/05 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.41% | 35Cr | |
+73.24% | 1.24TCr | |
-19.09% | 781.23Cr | |
+5.88% | 640.26Cr | |
+13.24% | 545.46Cr | |
+38.48% | 501.37Cr | |
-17.30% | 483.82Cr | |
-19.78% | 419.43Cr | |
-29.53% | 269.18Cr | |
+47.29% | 238.57Cr |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Full Year 2024